Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04469868 · ClinicalTrials.gov registry record · NA
No Opioids PrescrIptions On Discharge After Surgery
A NA study of Surgery and Postoperative Pain, sponsored by Albany Medical College.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT04469868: Completed NA study of Surgery and Postoperative Pain, sponsored by Albany Medical College.
NCT04469868 is a NA study of Surgery and Postoperative Pain that has completed, run by Albany Medical College. The registered enrollment target is 350 participants, below the 52,849-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04469868, a NA study of Surgery and Postoperative Pain, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
Opioid analgesics are routinely prescribed for these patients for post-operative pain control. Even a short exposure to opioids in opioid-naïve patients following minor or major surgery has been associated with de novo habitual or persistent use of opioids in 5-30% of patients. The goal of the study to eliminate the use of outpatient opioids prescriptions after major urologic surgery.
Primary Outcome
Patients will be discharged with no or few opioids after surgery along with instruction on how to use non-opioid analgesic measures.
Conditions Studied
Interventions
- BEHAVIORAL No opioids at discharge
Study Locations (1)
New York
- Albany Medical Center - Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2018-12-15 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
What the finished NCT04469868 record still lists
NCT04469868 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 52,849-participant average among 120 other Surgery trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which No opioids at discharge is the first listed.
NCT04469868 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04469868 about?
NCT04469868 is a clinical study titled "No Opioids PrescrIptions On Discharge After Surgery". Opioid analgesics are routinely prescribed for these patients for post-operative pain control. Even a short exposure to opioids in opioid-naïve patients following minor or major surgery has been associated with de novo habitual or persistent use of opioids in 5-30% of patients. The goal of the study...
What is the current status of trial NCT04469868?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2018-12-15. Estimated completion is 2024-04-01.
What conditions does trial NCT04469868 study?
This clinical trial studies the following conditions: Surgery, Postoperative Pain, Opioid Use, Prescription Drug Abuse and Dependency.
What interventions are being tested in trial NCT04469868?
The interventions under investigation include: No opioids at discharge (BEHAVIORAL).
Who is sponsoring clinical trial NCT04469868?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04469868 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04469868's enrollment target sits among peer trials
350 26th of 120 higher than 94 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
RECRUITING · NA
-
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
RECRUITING · NA
-
Ultrasound Evaluation for Improving Patient Selection in vNOTES
RECRUITING · NA
-
Gastric US in ICU Patient
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI